Helping convey the message that clinical research trials are safe is what my primary objective is here at Avail Clinical Research. We are here to help and do it in a way that is safe. We design our research studies to test the safety and efficacy of treatments for humans, and in order to do that clinical research studies are divided into four phases:

PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

PHASE III TRIALS: Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide an adequate basis for physician labeling.

PHASE IV TRIALS: Post-marketing studies to delineate additional information including the drug’s risks, benefits, and optimal use.

We’ve recently been conducting clinical research trials for tobacco consumers, and we are searching for candidates who are not wanting to quit using products like SNUS, chew and dip. This is just one of the research studies we’ve been working on here in DeLand, Florida. Some of our investigational treatments have shown promising results, but there is a need to do additional research studies to test investigational methods that may help us understand your condition.

The research studies will enroll those who are current tobacco users, and in order to participate in the studies volunteers must be users of SNUS (pronounced – ’snooze’), chew, or dip. In addition they should have the no desire to quit using either of these products.

Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our clinical trials, contact Avail Clinical Research at 386.310.1334, or at www.AvailClinical.com.